News

Biopharma company's 100,000 square-foot California center will house its blood cancer treatments

HCP-driven partnership calls for greater engagement across the life science sector

Designation is powered by CDMO’s sustainability focus

Distributor is able to reach more patients as a result  

The latest people news happenings over the past month

Microbial production site’s manufacturing capacity to increase by 70% upon completion

Digital therapy will help support mental health of cancer patients

New facility will focus on company’s temperature-controlled pallet shipper rental program

CDMO boosts capabilities at Cambridge location

Will feature drug discovery, gene and RNA therapy technology

Decision due to European Commission decreasing its order

Commercial GMP facility is first of its kind in the Emerald Isle, the company says

With deal, drug wholesaler grows its biopharma services platform

With integrated supply chain platform, strategic partnership looks to accelerate cell therapy program development

ESG-friendly Crēdo Go expected to benefit the pharma industry

Collaboration will be powered by tech company’s AI services

Acquisition helps grow its CDMO capabilities

In effort to assist pharma supply chain, company’s end goal is net-zero emissions by 2040

“Amplified iteration” advances the company’s ‘select, connect, discover’ insights management solution launched last year

Financial commitment expected to benefit capabilities of single-use assemblies

Allows CDMO’s regulatory, consulting services to further expand into the pharma market

Law firm to feature life sciences practice in New Jersey and Philadelphia

Among goals, product aims to mitigate supply chain risk for pharma and biotech industries

Varcode’s variable barcode records temperature and time out-of-compliance for pharma and perishables

Allows CDMO to enhance its therapeutic and vaccine offerings

Advanco provides software solution architecture and configuration while Vantage delivers design, implementation, and validation services

The Advanced Pharmaceutical Manufacturing (APM) Cluster, led by the Virginia Biotechnology Research Partnership Authority (Activation Capital), secures almost $53 million from the EDA’s Build Back Better Regional Challenge to boost Virginia’s pharmaceutical industry

Location expands company’s pharmacovigilance, regulatory affairs services